Literature DB >> 19706590

Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.

Carl Bose1, Linda J Van Marter, Matthew Laughon, T Michael O'Shea, Elizabeth N Allred, Padmani Karna, Richard A Ehrenkranz, Kim Boggess, Alan Leviton.   

Abstract

OBJECTIVE: Improvement in survival of extremely premature infants over the past several decades has resulted in an increase in the number of infants with chronic lung disease (CLD). Historical neonatal exposures associated with CLD now less frequently precede the disease. There is now increasing interest in exposures and events before delivery that predict CLD. The objective of this study was to identify current prenatal predictors of CLD.
METHODS: We collected data about prenatal, placental, and neonatal characteristics of 1241 newborns who were delivered before completion of the 28th week of gestation. Associations between prenatal factors, microbiologic and histologic characteristics of the placenta, and selected neonatal characteristics and CLD risk were first evaluated in univariate analyses. Subsequent multivariate analyses investigated the contribution of prenatal factors, particularly fetal growth restriction (FGR), to CLD risk.
RESULTS: Among the prenatal factors, birth weight z scores, used as a marker of FGR, provided the most information about CLD risk. Indicators of placental inflammation and infection were not associated with increased risk of CLD. Within nearly all strata of prenatal, placental, and neonatal variables, growth-restricted infants were at increased CLD risk, compared with infants who were not growth-restricted. FGR was the only maternal or prenatal characteristic that was highly predictive of CLD after adjustment for other risk factors.
CONCLUSIONS: FGR is independently associated with the risk of CLD. Thus, factors that control fetal somatic growth may have a significant impact on vulnerability to lung injury and in this way increase CLD risk.

Entities:  

Mesh:

Year:  2009        PMID: 19706590      PMCID: PMC2891899          DOI: 10.1542/peds.2008-3249

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  41 in total

1.  Intrauterine growth restriction increases morbidity and mortality among premature neonates.

Authors:  Thomas J Garite; Reese Clark; James A Thorp
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

2.  Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994.

Authors:  T M O'Shea; J S Preisser; K L Klinepeter; R G Dillard
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

3.  Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation.

Authors:  C Bardin; P Zelkowitz; A Papageorgiou
Journal:  Pediatrics       Date:  1997-08       Impact factor: 7.124

4.  New birthweight and head circumference centiles for gestational ages 24 to 42 weeks.

Authors:  P L Yudkin; M Aboualfa; J A Eyre; C W Redman; A R Wilkinson
Journal:  Early Hum Dev       Date:  1987-01       Impact factor: 2.079

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  Intrauterine growth curves based on ultrasonically estimated foetal weights.

Authors:  K Marsál; P H Persson; T Larsen; H Lilja; A Selbing; B Sultan
Journal:  Acta Paediatr       Date:  1996-07       Impact factor: 2.299

7.  Increased morbidity in severe early intrauterine growth restriction.

Authors:  Susan W Aucott; Pamela K Donohue; Frances J Northington
Journal:  J Perinatol       Date:  2004-07       Impact factor: 2.521

8.  Impact of improved survival of very low-birth-weight infants on incidence and severity of bronchopulmonary dysplasia.

Authors:  Thomas M Berger; Iris I Bachmann; Mark Adams; Gregor Schubiger
Journal:  Biol Neonate       Date:  2004-06-10

9.  Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.

Authors:  K L Watterberg; L M Demers; S M Scott; S Murphy
Journal:  Pediatrics       Date:  1996-02       Impact factor: 7.124

Review 10.  Necrotizing enterocolitis: treatment based on staging criteria.

Authors:  M C Walsh; R M Kliegman
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

View more
  88 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

Review 2.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

3.  Genomic Insights into Respiratory Outcomes after Preterm Birth.

Authors:  Steven H Abman; Peter Mourani; Brandie Wagner
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 4.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

5.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

Authors:  Jen-Ruey Tang; S Ananth Karumanchi; Gregory Seedorf; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

6.  Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort Study.

Authors:  Héloïse Torchin; Pierre-Yves Ancel; François Goffinet; Jean-Michel Hascoët; Patrick Truffert; Diep Tran; Cécile Lebeaux; Pierre-Henri Jarreau
Journal:  Pediatrics       Date:  2016-02-18       Impact factor: 7.124

7.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

Authors:  Paul J Rozance; Gregory J Seedorf; Alicia Brown; Gates Roe; Meghan C O'Meara; Jason Gien; Jen-Ruey Tang; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

8.  Adverse early-life environment impairs postnatal lung development in mice.

Authors:  Pui Y Lai; Xigang Jing; Teresa Michalkiewicz; Brianna Entringer; Xingrao Ke; Amber Majnik; Alison J Kriegel; Pengyuan Liu; Robert H Lane; Girija G Konduri
Journal:  Physiol Genomics       Date:  2019-08-02       Impact factor: 3.107

Review 9.  Ureaplasma and BPD.

Authors:  Suhas G Kallapur; Boris W Kramer; Alan H Jobe
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann
Journal:  Acta Paediatr       Date:  2015-12-23       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.